EICHORCondition: Atopic Dermatitis · Sponsor: Vanda Pharmaceuticals
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Male and non-pregnant, non-lactating female patients aged 18 - 70 years (inclusive); * Diagnosed with atopic dermatitis; * Suffering from chronic pruritus; * Body Mass Index (BMI) of ≥18 and ≤40 kg/m2 Exclusion Criteria: * Chronic pruritus due to condition other than atopic dermatitis (AD); * A positive test for drugs of abuse at the screening or evaluation visits; * Exposure to any investigational medication in the past 60 days
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Vanda Investigational Site | Hoover, Alabama, United States | — |
| Vanda Investigational Site | Tempe, Arizona, United States | — |
| Vanda Investigational Site | Encino, California, United States | — |
| Vanda Investigational Site | Fountain Valley, California, United States | — |
| Vanda Investigational Site | Laguna Hills, California, United States | — |
| Vanda Investigational Site | Lomita, California, United States | — |
| Vanda Investigational Site | Los Angeles, California, United States | — |
| Vanda Investigational Site | Los Angeles, California, United States | — |
| Vanda Investigational Site | Los Angeles, California, United States | — |
| Vanda Investigational Site | Denver, Colorado, United States | — |
| Vanda Investigational Site | Clearwater, Florida, United States | — |
| Vanda Investigational Site | Miami, Florida, United States | — |
+ 39 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04140695